Pharmacolog has signed an agreement with Birmingham Children´s Hospital NHS Foundation Trust (BCHNFT) for a technical evaluation of DrugLog to increase patient safety in the treatment of children with intravenous medical drugs.
The agreement with BCHNFT include 2 parts. Firstly, technical and functional tests at the hospital pharmacy och hospital wards, and secondly a research study of DrugLog in a clinical environment in different IV treatments of children.
The University Hospital in Geneva (HUG) have signed a user agreement to use DrugLog® in their clinical operation for quality assurance of toxic drugs. HUG is the first clinic in Europe to start using the DrugLog® system in daily operation.
“We are very pleased that HUG have accepted our offer. No other clinic has tested DrugLog® more thoroughly than HUG. It is therefore a very strong acknowledgment for DrugLog®. We hope this will encourage other leading hospitals in Europe to start using the system to improve production quality and patient safety.” says Karl-Erik Carlström, CEO Pharmacolog AB
We want to take the opportunity to wish all of you a nice summer. We are aware that this is more important for those of you that live in the Nordic countries like us.
Even though the number of people available in the office sometime goes down the office will be open as normal during July. And we are available on e-mail and phone as normal.
Do not hesitate to contact us at your best convenience.
The Pharmacolog team
CTC signs breakthrough order for Pharmacolog
Clinical Trial Consultants AB have signed an order to use DrugLog® in their hospital based test site in Uppsala. It is of outmost importance to have a very high accuracy in the drugs used for testing on humans in early stage clinical trials. Both to guarantee the safety of the patients and to get a representative result in the studies.
“This is a breakthrough for Pharmacolog and DrugLog®. We are very pleased to have this first installation in our home town.” says Karl-Erik Carlström, CEO
Press release, Swedish only
Pharmacolog appoints a new CEO
Hans Dahlin, Founder of Pharmacolog, hand over the position as CEO to Karl-Erik Carlström, previously Sales & Marketing Manager and Vice President.
Hans Dahlin will remain in an operative position with reasonability for innovations and research projects, in addition to his board membership.
At the same time Mats Högberg takes over the role as Sales & Marketing Manager and Vice President.